Great Britain Offers Israeli Life Sciences Companies to Conduct Clinical Trials in the UK
Latest announcement is part of a larger collaboration between both countries.
The UK has an advantage in conducting clinical trials in that everyone is insured and receives treatment through National Health Services (NHS). The NHS is the largest single healthcare provider in the world. With more than 4,000 life sciences companies in the UK, Great Britain’s life sciences cluster is well-poised to offer this innovative program to Israeli’s bio, pharma, and medical device companies.
Subscribe to our mailing list, and we'll keep you posted of the latest developments.